Syed Ahmed has Medical Oncology as his primary medical specialty. Their primary office is: 40215 Hwy 27 in Davenport, Florida.
There is an additional office location, for a total of two, for Syed Ahmed that can be viewed further down.
They're a part of the: Florida Cancer Specialists And Research Institute, Llc medical group which has around 380 members. You can call their office at 863-421-9705 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Pennsylvania State University College Of Medicine and graduated in 1992 (around 32 years of experience). They are listed as doing telehealth appointments.
Syed Ahmed
Florida Cancer Specialists And Research Institute, Llc
40215 Hwy 27
Davenport, Florida 33837
863-421-9705
Phone: 863-421-9705
Enter a starting address:
Additional Medical Specialties Include:
HEMATOLOGY, INTERNAL MEDICINE
Medical School: Pennsylvania State University College Of Medicine
Graduation Year: 1992
The Primary Medical Specialty for Syed Ahmed is listed as: Medical Oncology
Approximate Years of Experience: 32
PAC (PECOS ID)#: 2567505829
NPI #: 1700880697
NPI Created On: 06/08/2005
NPI Last Updated Listed as: 10/29/2021
Primary Taxonomy Code: 207RX0202X
License Number:
ME80993
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $125
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589669
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $15
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589671
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $24
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589673
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $11
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589677
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $15
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589675
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Drug or Biological: Biological
Product Category #2: Oncology
Name Of Drug #2:: IMBRUVICA
Associated Drug #2: 57962-140-09
Payments Total: $5
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589679
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: RYBREVANT
Open Associated Drug #1: 57894-501-01
Payments Total: $18
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589681
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: RYBREVANT
Open Associated Drug #1: 57894-501-01
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589683
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: BALVERSA
Associated Drug #2: 59676-030-56
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589685
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: RYBREVANT
Open Associated Drug #1: 57894-501-01
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788589687
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
1. Florida Cancer Specialists And Research Institute, Llc
1396 Whisper Cir
Sebring, FL 33870
Group Members: 380
Phone: 863-421-9705
Enter a starting address:
1503 Buenos Aires Blvd
The Villages Fl 32159-6823
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology
6420 W Newberry Rd E Wing
Gainesville Fl 32605-4308
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology
1396 Whisper Cir
Sebring Fl 33870-1204
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology
2848 Ctr Pointe Dr
Fort Myers Fl 33916-9521
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology
901 Tamiami Trl S
Venice Fl 34285-3668
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology
2231 Hwy 44 West 203
Inverness Fl 34453-3879
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology
View all 380 members of Florida Cancer Specialists And Research Institute, Llc medical group